Exagen Inc.
XGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $74,632 | $35,182 | $40,998 | $185,757 |
| - Cash | $22,036 | $36,493 | $62,391 | $99,442 |
| + Debt | $23,363 | $23,721 | $36,049 | $28,065 |
| Enterprise Value | $75,959 | $22,410 | $14,656 | $114,380 |
| Revenue | $55,641 | $52,548 | $45,563 | $48,299 |
| % Growth | 5.9% | 15.3% | -5.7% | – |
| Gross Profit | $33,112 | $29,456 | $21,349 | $27,711 |
| % Margin | 59.5% | 56.1% | 46.9% | 57.4% |
| EBITDA | -$11,145 | -$19,153 | -$43,664 | -$23,103 |
| % Margin | -20% | -36.4% | -95.8% | -47.8% |
| Net Income | -$15,115 | -$23,689 | -$47,387 | -$26,851 |
| % Margin | -27.2% | -45.1% | -104% | -55.6% |
| EPS Diluted | -0.83 | -1.34 | -2.77 | -1.68 |
| % Growth | 38.1% | 51.6% | -64.9% | – |
| Operating Cash Flow | -$13,279 | -$14,462 | -$32,144 | -$20,269 |
| Capital Expenditures | -$515 | -$828 | -$4,318 | -$2,370 |
| Free Cash Flow | -$13,794 | -$15,290 | -$36,462 | -$22,639 |